2017
Mechanisms of Disease and Natural History
Ziganshin B, Elefteriades J. Mechanisms of Disease and Natural History. 2017, 19-43. DOI: 10.1007/978-3-319-15192-2_2.Peer-Reviewed Original ResearchAortic diseaseNatural historyEndovascular treatment optionsThoracic aortic diseaseClassic open surgeryDiseased aortic wallEvidence-based criteriaMechanisms of diseaseAortic pathologyAortic ruptureLethal complicationOpen surgeryProphylactic treatmentEndovascular interventionTreatment optionsIndividual patientsAortic wallPersonalized managementMechanisms of developmentDiseasePatientsSuch treatmentTreatmentCurrent understandingComplications
2006
Matrix Metalloproteinases in Thoracic Aortic Aneurysm Disease
Botta D, Elefteriades J. Matrix Metalloproteinases in Thoracic Aortic Aneurysm Disease. International Journal Of Angiology 2006, 15: 1-8. DOI: 10.1007/s00547-006-2080-z.Peer-Reviewed Original ResearchAortic aneurysmMatrix metalloproteinasesThoracic aortic aneurysm diseaseAneurysmal aortic segmentsThoracic aortic aneurysmAortic aneurysm diseaseDiseased aortic wallPharmacologic therapySerum levelsAneurysm diseaseAortic segmentsMMP-9Aortic wallClinical monitoringMMP-1Tissue levelsAneurysmsMetalloproteinasesMMPsPivotal roleProteolytic enzymesSite of synthesisPathophysiologyTherapyDiseaseMatrix metalloproteinases in thoracic aortic aneurysm disease
Botta D, Elefteriades J. Matrix metalloproteinases in thoracic aortic aneurysm disease. International Journal Of Angiology 2006, 1-8. DOI: 10.1055/s-0031-1276527.Peer-Reviewed Original ResearchAortic aneurysmMatrix metalloproteinasesThoracic aortic aneurysm diseaseAneurysmal aortic segmentsThoracic aortic aneurysmAortic aneurysm diseaseDiseased aortic wallPharmacologic therapySerum levelsAneurysm diseaseAortic segmentsMMP-9Aortic wallClinical monitoringMMP-1Tissue levelsAneurysmsMetalloproteinasesMMPsPivotal roleProteolytic enzymesSite of synthesisPathophysiologyTherapyDisease